ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

The 15 Best Selling Drugs in 2017

Updated on December 14, 2017
Source

The 15 Best Selling Drugs in 2017

The pharmaceutical industry is forecasted to reach the 1.12 trillion USD in 2022. The industry has shown a steady growth of the 6.5% yearly during the last three years. The drugs that concentrate the pharmaceutical’s revenue are the latest generations of monoclonal antibodies, which are used as anti-neoplastic or medicines to treat cancer and immune modulators or medicines to treat autoimmune diseases. The 15 bestselling drugs represent 10% of the global market with 85 USD billion per year.

One of the reasons for the staggering sales figures is that the health care systems have improved around the world. Nowadays, the newly FDA approved drugs are available globally to treat anybody who needs them.

On the other hand, the most prescribed drug or the drug that is most widely used by patients around the world. It is the levothyroxine, which is taken by 21.5 million or patient only in the USA and its estimated as many as 10% or the earth population, who takes prescriptions, might take it. It is used to treat the thyroid gland hormones deficit, which is called hypothyroidism. Unfortunately, the pharmaceutical industry does not report individual drugs by country or region, which makes hard to get reliable information. The list of essential medicines might be at the top, but without a global estimate used, they cannot be quoted.

The top 15-bestselling drug list was created with the sales report from the USA insurance companies and the leading pharmaceutical sales reports for the 2016 and 2017.

15 Neulasta® (pegfilgrastim)

Net sales: 4.7 USD during 2016, a 3.4 % increase is expected for 2017

Indicated for Treatment of: Neutropenia, which is a decrease in the white cells count in the blood

Drug manufacturer:Amgen Inc.

Company’s headquarters country: United States

Neulasta® (pegfilgrastim) is a human made chemical, which imitates the natural substance secreted by the body that stimulates or induces the production and formation of a white cell type called neutrophils. The neutrophils prevent new and help fighting infections. This medicine is given to patients, who are taking anticancer drugs (chemotherapy) that destroy this type of white cells. Additionally, patients who were exposed to high levels or radiations.

14 LYRICA® (pregabalin)

Net sales: 4.97 USD during 2016, a - 5.4 % decrease is expected for 2017

Indicated for Treatment of severe neurogenic pain (pain caused by nerves)

Drug manufacturer: Pfizer

Company’s headquarters country: United States

LYRICA (pregabalin) is a widely prescribed drug for the treatment of nerves originated pain. Neuropathic pain associated with diabetic peripheral neuropathy, which is caused by the damage or destruction of the limbs nerves by the high levels of sugar in the blood. Post-herpetic neuralgia, which is the pain left after a herpes zoster infection. Fibromyalgia, which is a chronic pain syndrome characterized by multiples body’s pains. Neuropathic pain associated with spinal cord injury, which can be caused by herniated vertebral discs, nerves compressions, surgery or accidents.

13 EYLEA®(aflibercept)

Net sales: 5.05 USD during 2016, a 40 to 75% increase is expected for 2017

Indicated for Treatment of Diabetic Retinopathy, Age-related Macular Degeneration, Macular Edema following Retinal Vein Occlusion, and Diabetic Macular Edema

Drug manufacturer: Bayer and Regeneron Pharmaceutical

Company’s headquarters country: Germany and Ireland

EYLEA® (aflibercept) is a biomolecular drug developed by Regeneron pharmaceutical, which inhibits the abnormal blood vessel growth inside the eye. The medicine is used to treat the diabetic retinopathy, which is the proliferation of blood vessels in front of the retina causing multiples micro bleedings with together produce visual impairment by blocking the light from reaching the retina. Before the development of EYLEA® (aflibercept), the only treatment available for this medical condition was the laser ablation (destruction), now an injection inside the eye can control and improve the medical condition. Additionally, age-related macular degeneration, macular edema following retinal vein occlusion, and diabetic macular edema can be treated successfully with it.

Source

12 Xarelto®  (Rivaroxaban)

Net sales: 5.39 USD during 2016, a 25% increase is expected for 2017

Indicated for Treatment of blood’s clot prevention

Drug manufacturer: Janssen Biotech, Inc. and Bayer

Company’s headquarters country: The United States and Germany

XARELTO (Rivaroxaban) is a drug use to make the blood thinner and prevent the clot formation. The rivaroxaban attaches to a blood component called factor Xa and prevents the clots formation. The drug is used in order to avoid veins and arteries occlusion (blocked blood vessels). The medicine starts working 4 hours after its ingestion, and it is one of the most prescribed blood thinners worldwide. Currently, there are more than 24 millions of users globally.

11 Prevnar 13® (anti-pneumococci or anti-Streptococcus pneumoniae vaccine)

Net sales: 5.72 USD during 2016, a 30% increase is expected for 2017

Indicated for Treatment of: Prevention of pneumococci generalized infections.

Drug manufacturer: Wyeth Pharmaceuticals Inc. and Pfizer

Company’s headquarters country: United States

The PREVNAR 13 (anti-pneumococci or anti-Streptococcus pneumoniae vaccine), offer protection against 13 different types of Streptococcus pneumoniae bacteria, which can infect the lungs and produce pneumonia or lung infections. The Prevnar 13 vaccine is recommended for children from 6 weeks through 17 years and adults older than 50 years old to prevent the lung infections, and in some cases, the vaccine can protect against some types of brain infections in children.

10 Lantus®   (Insulin Glargine

Net sales: 6.05 USD during 2016, a – 2% decrease is expected for 2017

Indicated for Treatment of Type II Diabetes Mellitus (high blood sugar level)

Drug manufacturer: Sanofi

Company’s headquarters country: United States

LANTUS (Insulin glargine) is a long-acting insulin (insulin is a hormone secreted by the pancreas to control blood sugar level) with tries to imitate the natural secreted insulin. Because of the obesity epidemic and the genetic predisposition of black race and Hispanics to high blood sugar levels, the different medicines to low the blood sugar levels are on the rise. However, Lantus sales might decrease because the patent exclusively period already expired and other generic drugs are now available with the same chemical composition.

9 JANUVIA®(sitagliptin)

Net sales: 6.1 USD during 2016, a .02% increase is expected for 2017

Indicated for Treatment of Type II Diabetes Mellitus (high blood sugar level)

Drug manufacturer: Merck & Co., Inc.

Company’s headquarters country: United States

JANUVIA® (sitagliptin) is a pill to low the blood sugar level. The increased number of obese population and the simplicity to take just one pill per day make this drug one of the most prescribed treatment worldwide. The Januvia sales are expected to increase steadily by 20% per year during the next five years.

Source

8 Herceptin®(trastuzumab)

Net sales: 6.51 USD during 2016, a 4% increase is expected for 2017

Indicated for Treatment of Some types of breast and Gastric Cancers

Drug manufacturer: Genentech, Inc.

Company’s headquarters country: United States

Herceptin® (trastuzumab) is a monoclonal antibody used as an adjuvant for treatment of certain types of cancer of the breast and stomach. The Herceptin is administered in combination with other anti-cancer drugs. The usual treatment duration is 52 weeks.

7 AVASTIN® (bevacizumab)

Net sales: 6.51 USD during 2016, a 4% increase is expected for 2017

Indicated for Treatment of Some cancer of the bowel, kidney, lungs, and ovaries that spread through the body.

Drug manufacturer: Genentech, Inc.

Company’s headquarters country: United States

AVASTIN® (bevacizumab) is a monoclonal antibody used as an adjuvant for treatment of certain types of cancer of the bowel, kidney, lungs, and ovaries that spread through the body. The drug works by preventing the blood vessels from forming and reaching the tumors or cancer cells, which produce that the tumors or cancer cells reduce its size because it does not find enough blood to support it. The Avastin is advertised as the drug that starves the tumors. It is a monoclonal antibody, which prevents the formation of new blood vessels on the cancer cells. Avastin and Herceptin reports the same sales during 2016 and 2017

6 REVLIMID® (lenalidomide)

Net sales: 6.97 USD during 2016, a 16% increase is expected for 2017

Indicated for Treatment of Multiple myeloma (MM), Mantle cell lymphoma (MCL) and some types of Transfusion-dependent anemia

Drug manufacturer: Celgene

Company’s headquarters country: United States

REVLIMID® (lenalidomide) is a similar chemical product to the thalidomide with immunomodulatory, antineoplastic or anticancer, and antiangiogenic or prevent the new blood vessel growth and formation around the cancer cells. It works by inducing the cells auto-destruction (apoptosis), and it increases the cellular activity of a specific white cells line called Lymphocytes T4, which are natural killers of malignant and foreign cells.

5 REMICADE®(infliximab)

Net sales: 7.83 USD during 2016,

Indicated for Treatment of Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis Arthritis, Ankylosing Spondylitis, and Plaque Psoriasis.

Drug manufacturer: Janssen Biotech, Inc and Merck

Company’s headquarters country: United States

REMICADE® (infliximab) is one monoclonal antibody that got FDA approval in 1998 to treat certain autoimmune diseases. The Remicade works by blocking the action of a chemical compound called the TNFα, which is the primary responsible for local inflammation. Therefore, by blocking its response, the local inflammation is markedly reduced or even prevented decreasing the symptoms associated with it. This drug action is called immune suppressant because it inhibits or suppresses the immune system action.

Source

4 RITUXAN®(rituximab)

Net sales: 8.58 USD during 2016, a 25% increase is expected for 2017

Indicated for Treatment of some blood and lymph cancers, such as some Non–Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL). Additionally, it can be used to treat Rheumatoid Arthritis and Granulomatosis with polyangiitis

Drug manufacturer: Janssen Biotech, Inc and Merck

Company’s headquarters country: United States

RITUXAN® (rituximab) is a monoclonal antibody with immunomodulation actions that work on some white cells type called lymphocytes B and produce that some of them, which are CD20 died, by doing it they reduce the inflammation in the body.


3 ENBREL®(etanercept)

Net sales: 8.87 USD during 2016, a 2% increase is expected for 2017

Indicated for Treatment of Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Granulomatosis with polyangiitis

Drug manufacturer: Amgen

Company’s headquarters country: United States

ENBREL® (etanercept) is an immunomodulatory drug, which works by blocking the function of a chemical product called TNF alfa and beta. Etanercept binds to the TNF alfa and beta chemical products and blocks its action on the cell’s surface. It inhibits the local inflammatory response. The etanercept is used as the treatment of choice for various autoimmune diseases. It can be administered by an injection under the skin. Several devices and preparations are available for self-injection, making this drug efficient and convenient for patient use and disease control

2 HARVONI®(ledipasvir and sofosbuvir)

Net sales: 9.09 USD during 2016, a 100% increase is expected for 2017

Indicated for Treatment of Hepatitis C virus

Drug manufacturer: Gilead Sciences, Inc.

Company’s headquarters country: United States

HARVONI is a fixed-dose combination of ledipasvir and sofosbuvir, both drugs work by blocking the viral replication of the Hepatitis C virus. The Harvoni is the first treatment to prevent or revert the liver damage and in several cases the progression to liver cancer of the Hepatitis C virus. The Harvoni is the new hope for a definitive cure for chronic viral diseases and cancers. The Harvoni drug is taken by mouth as a single pill for 8 to 24 weeks. Afterward, the liver damage caused by the virus might be stopped or reversed. This medicine created a significant controversy for its high price, but in the long term, it is cheaper than the treatment of any of the natural disease progression complications and the liver cancer.

1 HUMIRA(adalimumab)

Net sales: 16.08 USD during 2016, an 11% increase is expected for 2017

Indicated for treatment of Rheumatoid arthritis, Crohn’s disease, Psoriasis, Juvenile Idiopathic Arthritis. Ulcerative Colitis, Ankylosing Spondylitis, Hidradenitis Suppurativa, and Uveitis

Drug manufacturer: AbbVie

Company’s headquarters country: United States

HUMIRA (adalimumab) is a monoclonal antibody, which reduces the autoimmune response and inflammation by blocking the chemical product called TNF alfa and by altering the cellular receptor for the TNF chemical products. Therefore, it reduces the inflammation markedly in joints and tissues. Humira is administered as an injection under the skin. It has been used for the last 0 years with excellent results improving the life quality and reducing the pain and deformation of the joint diseases.

Source

The top-selling drugs are molecules designed in the laboratory to mimic some immunological functions of the chemical products secreted and produce for healthy immune cells. Those human-made created molecules are particular in its role and act on unique areas of the cell limiting the side effect and improving the target organ or tissues. The future of these new chemical compound is bright, and the medical technology is every day closer to find effective remedies and cures for the chronic and fatal diseases.

The pharmaceutical industry will maintain an economic growth during the next decades. Probably the genetically modified molecules will be leading the sales during the next ten years.





Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)